Precision-guided sterile insect technique using Cas9-expressing insect strains programmed with target-specific guide RNAs to control corn pests like Peregrinus maidis, reducing crop losses from feeding damage and virus transmission.
This research program develops a novel genetic pest management strategy targeting Peregrinus maidis, a hemipteran insect pest that causes significant economic damage to maize through feeding and transmission of maize mosaic virus. The approach leverages CRISPR-Cas9 gene editing technology to create programmable insect strains suitable for population control and pathogen vector suppression. The technology addresses the urgent need for novel control strategies as herbivorous insects continue to cause enormous crop losses globally. The Hawaii maize production environment provides an advantageous testing ground for validating this system.
Core technology:
Validated capabilities:
Potential applications:
The technology is at an early-to-mid development stage (TRL 3-4). Proof-of-principle experiments have demonstrated successful Cas9 expression and CRISPR-mediated gene editing in P. maidis. Next-phase validation will involve mining the genome for suitable gene targets, developing gRNA-expressing strains, and conducting crosses with Cas9-expressing strains to confirm gene-edited offspring production. The project aims to establish feasibility and effectiveness of genetic control strategies, with outcomes expected to provide scalable pest management solutions applicable beyond maize to other crop systems.
North Carolina State University is a large, comprehensive public land‑grant research university in Raleigh. Its on‑campus research and technology park co‑locates corporate R&D groups, government partners, and faculty labs, enabling shared facilities, prototyping, and agile contracting. Located in North Carolina’s Research Triangle, partners tap a dense regional ecosystem while engaging through a statewide extension network and a mature co‑op program that deliver field deployment and workforce pipelines. Multiple pilot and demonstration facilities support scale‑up and validation toward pre‑commercial readiness. Research is supported by competitive funding from major federal agencies, including NSF, USDA, DOE, and DOD, and a dedicated technology transfer office with clear IP pathways helps accelerate commercialization.